Cargando…

Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis

Cirrhosis is the end result of liver fibrosis in chronic liver diseases. Studying the mechanisms of its development and developing measures to slow down and regress it based on this knowledge seem to be important tasks for medicine. Currently, disorders of the gut–liver axis have great importance in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maslennikov, Roman, Poluektova, Elena, Zolnikova, Oxana, Sedova, Alla, Kurbatova, Anastasia, Shulpekova, Yulia, Dzhakhaya, Natyia, Kardasheva, Svetlana, Nadinskaia, Maria, Bueverova, Elena, Nechaev, Vladimir, Karchevskaya, Anna, Ivashkin, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671141/ https://www.ncbi.nlm.nih.gov/pubmed/38003692 http://dx.doi.org/10.3390/ijms242216502

Ejemplares similares

The Concept of Folic Acid in Health and Disease
por: Shulpekova, Yulia, et al.
Publicado: (2021)

Metabolic activity of intestinal microflora in patients with bronchial asthma
por: Ivashkin, Vladimir, et al.
Publicado: (2019)

A Metabolic Activity Recovery of the Intestinal Microbiota in the Patients with Bronchial Asthma
por: Ozimek, Mariusz, et al.
Publicado: (2022)

The Role of Bile Acids in the Human Body and in the Development of Diseases
por: Shulpekova, Yulia, et al.
Publicado: (2022)

Early viral versus late antibiotic-associated diarrhea in novel coronavirus infection
por: Maslennikov, Roman, et al.
Publicado: (2021)

The study of the relevance of macro- and microelements in the hair of young wrestlers depending on the style of wrestling
por: Zaborova, Victoria, et al.
Publicado: (2022)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

A Recent Ten-Year Perspective: Bile Acid Metabolism and Signaling
por: Shulpekova, Yulia, et al.
Publicado: (2022)

Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?
por: Maslennikov, Roman, et al.
Publicado: (2021)

Probiotics in hepatology: An update
por: Maslennikov, Roman, et al.
Publicado: (2021)

Food Intolerance: The Role of Histamine
por: Shulpekova, Yulia O., et al.
Publicado: (2021)

Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial
por: Maslennikov, Roman, et al.
Publicado: (2022)

Clostridioides difficile co-infection in patients with COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2022)

Probiotic Saccharomyces boulardii in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis
por: Efremova, Irina, et al.
Publicado: (2023)

Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis
por: Efremova, Irina, et al.
Publicado: (2023)

Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial
por: Kovaleva, Aleksandra, et al.
Publicado: (2023)

Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Associations between Physical Activity and Kyphosis and Lumbar Lordosis Abnormalities, Pain, and Quality of Life in Healthy Older Adults: A Cross-Sectional Study
por: Zaborova, Victoria, et al.
Publicado: (2023)

Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study
por: Ivashkin, Vladimir, et al.
Publicado: (2023)

NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2018)

Impact of vaccination against the novel coronavirus infection (COVID-19) with Sputnik V on mortality during the delta variant surge
por: Dmitrieva, Ksenia, et al.
Publicado: (2023)

Epidemiology of small intestinal bacterial overgrowth
por: Efremova, Irina, et al.
Publicado: (2023)

Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
por: Maslennikov, Roman, et al.
Publicado: (2023)

Dos ataques de diarrea consecutivos en 15 pacientes de COVID-19: uno asociado con antibióticos posterior a uno viral
por: Maslennikov, R., et al.
Publicado: (2022)

Two consecutive attacks of diarrhea in 15 COVID-19 patients: An antibiotic-associated one following the viral one()
por: Maslennikov, R., et al.
Publicado: (2022)

Immune disorders and rheumatologic manifestations of viral hepatitis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT
por: Ivashkin, Vladimir T., et al.
Publicado: (2019)

Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
por: Mamieva, Zarina, et al.
Publicado: (2022)

Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial
por: Ivashkin, Vladimir, et al.
Publicado: (2021)

Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
por: Nadinskaia, Maria, et al.
Publicado: (2021)

Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19)
por: Maslennikov, Roman, et al.
Publicado: (2021)

Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2021)

Rapidly Progressive Portal Cavernoma Cholangiopathy in a Patient With Infeasible Decompressive Shunt Surgery
por: Nadinskaia, Maria Yu, et al.
Publicado: (2023)

Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome
por: Ivashkin, V., et al.
Publicado: (2021)

Meiotic Chromosome Contacts as a Plausible Prelude for Robertsonian Translocations
por: Matveevsky, Sergey, et al.
Publicado: (2020)

Controlled Structure of Polyester/Hydroxyapatite Microparticles Fabricated via Pickering Emulsion Approach
por: Minaev, Nikita V., et al.
Publicado: (2022)

The Effect of Anti-Chemokine Oral Drug XC8 on Cough Triggered by The Agonists of TRPA1 But Not TRPV1 Channels in Guinea Pigs
por: Romanova, Julia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0kunkr0aoobo5q5pcic9lep7eb